Navigation Links
ASPIRE Independent Review Board Announces 10 Ways to Protect Participants' Rights in Clinical Drug Trials and Optimize Results From Research
Date:6/9/2008

ASPIRE IRB Is Exhibiting at Bio International Convention in San Diego June

17-20 Currently, over 54,255 Trials with Locations in 154 Countries Are Taking

Place

SAN DIEGO, June 9 /PRNewswire/ -- ASPIRE IRB (http://www.aspire-irb.com), an Independent Review Board (IRB), is responsible for overseeing research and protecting the rights and welfare of people participating in clinical trials. ASPIRE IRB partners with drug manufacturers and research companies to get the best results from clinical drug trials and protect the rights and welfare of participants. "Making sure research is being implemented correctly is critical to the success of the study. Each study is unique. For instance people with Schizophrenia can tolerate a higher dose of particular drugs than people without the disorder. Races, because of genetics, react differently as well," explains Alycia Huston, COO of ASPIRE IRB.

The FDA and HHS regulations empower Independent Review Boards to approve or disapprove research and require modifications. They are made up of physicians, scientists, nonscientists, community members and associates affiliated with the IRB. A clinical trial CANNOT take place without an Independent Review Board.

Hundreds of thousands of people participate in clinical trials with the hope of finding relief and or to help others. Research is essential to finding cures and treatments for conditions and diseases. Being a member of a clinical trial is a big decision. It is essential for people to know their rights and understand how clinical trials work. They follow a defined protocol or study plan. It is designed to protect the health of participants and answer specific research questions.

Participating in clinical trials provides hope, can save lives and help others.

"Clinical trials for Cancer were instrumental in extending my life," states Mercie Madrid. Another participant, Mike Means, says, "I participated in a clinical trial for Psoriasis and my condition improved dramatically."

ASPIRE IRB's 10 Ways to Protect Participants' Rights and Maximize Results for Clinical Research
1) Participants can decide not to participate in the research study with

NO penalty or loss of benefits any time.

2) Participants can ask any questions that occur before, during or after

the study.

3) Be Informed. Get a copy of the consent form, the main source of

information for the study.

4) Ask the principal investigator as many questions as needed to

understand the trial.

5) No legal rights are waived by signing a consent form.

6) Ethical and legal codes governing medical practices apply to clinical

trials.

7) Be prompt to all scheduled appointments.

8) Call the research facility if there is a reaction to a drug or device

immediately.

9) Follow the study related instructions that are given to you.

10) Certain studies may expect more visits than regular care. This may

affect employment.

About ASPIRE IRB http://www.aspire-irb.com

ASPIRE IRB is a privately owned certified Women's Business Enterprise headquartered in San Diego, CA. They oversee clinical research studies. They review and approve any research involving human participants with the aim to protect their rights and welfare. Their goal is to make sure the protocol is well-designed and the risks are as minimal as possible. ASPIRE has overseen clinical drug trials for Cancer, Psoriasis, Schizophrenia, Depression, Multiple Sclerosis, Pain, Obesity, Dermatology, Heart Disease, Diabetes, Hyperactivity, Alzheimer's Disease, Sleep Disorders, Garlic, supplements and more. Clients include: Pfizer, Covance, PPD, Takeda, Sanofi-Aventis, Wyeth, Charles River, MRA and J&J.


'/>"/>
SOURCE ASPIRE IRB
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Promise of Vicals CMV Vaccine Noted by Independent Experts
2. Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer
3. Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City
4. Independent Studies Report on Possible Roles for Cylexs Immune Cell Function Assay in Monitoring of Heart and Lung Transplant Recipients
5. Longevinex(R) Found to be Superior to Green Tea Molecule in Independent Human Study
6. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
7. Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms
8. Independent Clinical Results Confirm Up to a 7-Centimeter Reduction in Body Circumference Using UltraShape(TM) Non-Invasive Fat Reduction and Body Contouring System
9. Facet Solutions AFRS(TM) Demonstrates Biomechanical Advantages Over Dynamic Stabilization in Independent Testing
10. Video: New Research Discovers Independent Brain Networks Control Human Walking
11. CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb. 24, 2017 Juan ... & Associates PC , a boutique securities firm headquartered ... York City , announces that a class action ... Massachusetts  against Inotek Pharmaceuticals Corporation (NASDAQ: ... the Company,s securities between July 23, 2015 and December 30, ...
(Date:2/24/2017)... YORK , Feb. 23, 2017 Report analyzes ... report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... and forecasts are provided for the period 2015 through 2022. ... Market data and analytics are derived from primary and secondary ...
(Date:2/24/2017)... Australie, le 24 février 2017 ITL Limited, ( ASX : ... innovante, est ravie d,annoncer les excellents résultats semestriels clos ... précédente correspondante. Une présentation complète « Résultats et mise à ... ici . Faits marquants ... (Déc. 2015 : 1,04 million $ ; en hausse de 104 %) ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... WHAT: , ... and recognition opportunities as well as advocacy for the state and region‘s technology ... February 23. The Council's Innovation Forecast event highlights innovation throughout the region ...
(Date:2/24/2017)... ... February 24, 2017 , ... In the Health Care ... a top priority because it’s not if you will be attacked, but when.” However, ... it comes to digital health care. , Improvements in auditing and monitoring have taken ...
(Date:2/24/2017)... ... February 24, 2017 , ... With ProGlass Prism users now ... . Users have total control over position, rotation, distortion, edge softness, edge blur, chromatic ... Cut Pro X. , With ProGlass Prism users are given the tools and ...
(Date:2/24/2017)... ... ... Fiber Network (IFN) President and CEO Kelly C. Dyer recently announced that he will ... the Management Committee when IFN was originally formed in 2002 where he was ultimately ... of the business plan. He became the first paid employee of IFN in ...
(Date:2/24/2017)... ... February 24, 2017 , ... Castle Farms, ... their Military Wedding Giveaway, with the winning couple announced on Feb. 14, 2017, ... generously donated from local vendors: A Matter of Taste, Ryan Rousseau Enterprises, A ...
Breaking Medicine News(10 mins):